iBio, Inc. (IBIO)
1.42
-0.01
(-0.70%)
USD |
NASDAQ |
Aug 24, 16:00
1.40
-0.02
(-1.41%)
After-Hours: 20:00
iBio Shareholders Equity (Quarterly) : 77.54M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 77.54M |
| December 31, 2025 | 56.56M |
| September 30, 2025 | 56.04M |
| June 30, 2025 | 14.88M |
| March 31, 2025 | 11.38M |
| December 31, 2024 | 13.90M |
| September 30, 2024 | 17.75M |
| June 30, 2024 | 21.32M |
| March 31, 2024 | 24.86M |
| December 31, 2023 | 9.197M |
| September 30, 2023 | 13.21M |
| June 30, 2023 | 15.38M |
| March 31, 2023 | 17.39M |
| December 31, 2022 | 18.82M |
| September 30, 2022 | 48.37M |
| June 30, 2022 | 63.48M |
| March 31, 2022 | 79.38M |
| December 31, 2021 | 90.60M |
| September 30, 2021 | 100.54M |
| June 30, 2021 | 108.58M |
| March 31, 2021 | 104.84M |
| December 31, 2020 | 107.34M |
| September 30, 2020 | 80.05M |
| June 30, 2020 | 56.62M |
| March 31, 2020 | 3.966M |
| Date | Value |
|---|---|
| December 31, 2019 | -0.511M |
| September 30, 2019 | -1.933M |
| June 30, 2019 | 2.463M |
| March 31, 2019 | 6.907M |
| December 31, 2018 | 11.08M |
| September 30, 2018 | 13.03M |
| June 30, 2018 | 16.17M |
| March 31, 2018 | 4.154M |
| December 31, 2017 | 7.812M |
| September 30, 2017 | 6.293M |
| June 30, 2017 | 8.914M |
| March 31, 2017 | 12.95M |
| December 31, 2016 | 4.153M |
| September 30, 2016 | 7.141M |
| June 30, 2016 | 9.937M |
| March 31, 2016 | 8.265M |
| December 31, 2015 | 7.878M |
| September 30, 2015 | 9.809M |
| June 30, 2015 | 11.23M |
| March 31, 2015 | 10.19M |
| December 31, 2014 | 9.567M |
| September 30, 2014 | 5.439M |
| June 30, 2014 | 6.099M |
| March 31, 2014 | 7.001M |
| December 31, 2013 | 7.954M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | 246.22M |
| Ocugen, Inc. | -16.56M |
| CytomX Therapeutics, Inc. | 302.07M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 85.83M |
| Total Liabilities (Quarterly) | 8.297M |
| Debt to Equity Ratio | 0.03 |
| Current Ratio | 11.88 |
| Net Debt Paydown Yield | 0.56% |